Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 37 38 39 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Two Blades Foundation–Univ Halle: TAL Code technology, 201205 excl license for commercial use in plants existent 2012-05-01
Cardinal Health–Qiagen: molecular diagnostics, 201204– distribution of Qiagen systems + kits to smaller + mid-sized US hospitals by Cardinal Health 2012-04-30
Gen-Probe–Hologic: investment, 201204–201208 acquisition $3.8b in cash $82.75/share 2012-04-30
Quotient Bioresearch–Biotrend: sample labelling services, 201204– collab supply of Iodine-125 labelling services by Anawa Trading SA 2012-04-30
Analytical Perspectives of North Carolina–SGS: investment, 201204 acquisition 2012-04-27
Omega Scientific–Ionicon: mass spectrometer, 201204– distribution + support of Ioncion PTR-MS instruments by Omega in Malaysia 2012-04-27
Omega Scientific–Ionicon: mass spectrometer, 201204– distribution + support of Ioncion PTR-MS instruments by Omega in Singapore 2012-04-27
Omega Scientific–Ionicon: mass spectrometer, 201204– distribution + support of Ioncion PTR-MS instruments by Omega in Thailand 2012-04-27
Active Biotech–Evotec: drug discovery services, 201204– service €na expansion medicinal chemistry services drug optimisation 2012-04-26
Futalis–High-Tech Gründerfonds: investment, 201204 seed financing from HTGF 2012-04-26
Innovacell–SEVERAL: investment, 201204– capital increase €8.3m in two tranches 2012-04-26
Rhön-Klinikum–Fresenius: investment, 201204–201206 NOT REALISED cash tender offer €3.1b €22.5/share OFFER FAILED 2012-04-26
JnJ–Artes Biotechnology: cell line development, 201204– collab developm + supply of Hansenula cell lines to Crucell for two vaccines 2012-04-24
ConoGenetix–Bavaria (govt): investment, 201204 financing round Series A totalling €1.5m incl returning investor BioM AG 2012-04-23
ConoGenetix–Mey Capital Matrix: investment, 201204 financing round Series A totalling €1.5m incl lead investor Mey Capital Matrix GmbH 2012-04-23
ConoGenetix–SEVERAL: investment, 201204 financing round Series A €1.5m lead investor Mey Capital Matrix + co-investor BioM AG 2012-04-23
AJ Roboscreen–Analytik Jena: investment, 201204 acquisition of remaining shares with resulting 100% ownership by Analytik Jena AG 2012-04-20
4SC–Crelux: drug discovery services, 201204– strategic alliance offering integrated drug discovery services by 4SC Discovery + Crelux 2012-04-18
KonTEM–High-Tech Gründerfonds: investment, 201204 investment by HTGF 2012-04-17
Oncgnostics–High-Tech Gründerfonds: investment, 201204 seed funding from HTGF + STIFT 2012-04-16
Oncgnostics–SEVERAL: investment, 201204 seed funding from HTGF + STIFT 2012-04-16
Oncgnostics–Thuringia (govt): investment, 201204 seed funding from HTGF + STIFT 2012-04-16
Bayer–KWS: plant breeding, 201204– collab co-developm breeding of herbicide-resistant varieties for weed control system Bayer CropScience 2012-04-12
Aleva Neurotherapeutics–SEVERAL: investment, 201204 financing round Series B CHF4m lead + new investor Banexi Ventures Partners 2012-04-10
Bipharma–Biofrontera: 5-aminolevulinic acid, 201204– excl marketing + distribution of Ameluz in Benelux by Bipharma NV 2012-04-04
ZIM Plant Technology–High-Tech Gründerfonds: investment, 201204 investment by HTGF 2012-04-04
Henkel–4SC: compound screening, 201204– collab computerised screening to identify laundry detergent ingredients 4SC Discovery GmbH 2012-04-02
Bayer–Piramal: investment, 201204 acquisition of molecular imaging business from Bayer Healthcare 2012-04-01
Merck (DE)–Kadimastem: drug discovery services, 201204– supply 5y framework agreem for use of functional tissues for MS drug screening 2012-04-01
Thermo Fisher–Peak Scientific: gas generator, 201203 collab Genius 1022 nitrogen generator specifically developed for Thermo’s Q Exactive system 2012-03-30
Allergan–Biofrontera: 5-aminolevulinic acid, 201203– excl marketing + distribution of Ameluz in Spain TERMINATED 11/14 2012-03-29
Altona Diagnostics–EU (govt): grant, 201203– EFRE funding €4.63m for ADT + BNI for €9m joint tropical disease project 2012-03-29
Altona Diagnostics–Hamburg (govt): grant, 201203– funding €400k for ADT + BNI for €9m joint tropical disease project 2012-03-29
Altona Diagnostics–Leibniz-Gemeinschaft: molecular diagnostics, 201203– collab tropical diasease biobank + developm of respective tests ADT + BNI 2012-03-29
Leibniz-Gemeinschaft–EU (govt): grant, 201203– EFRE funding €4.63m for ADT + BNI for €9m joint tropical disease project 2012-03-29
Leibniz-Gemeinschaft–Hamburg (govt): grant, 201203– funding €400k for ADT + BNI for €9m joint tropical disease project 2012-03-29
Protagen–Kairos GmbH: biobank management s/w, 201203– collab marketing + sales by Protagen 2012-03-29
GATC Biotech–Hamilton: lab automation equipment, 201203 supply existent fleet of Hamilton robotics at GATC Cologence Sequencing Centre 2012-03-28
Promethera–Boehringer: investment, 201203 financing round Series B totalling €17m incl new investor Boehringer Ingelheim Venture Fund 2012-03-28
Promethera–SEVERAL: investment, 201203 financing round Series B €17m incl new investors Boehringer + Shire + Mitsui 2012-03-28
Univ Oslo–Thermo Fisher: mass spectrometer, 201203 supply Q-Exactive Orbitrap MS to Bioanalytics@UiO for proteomics + metabolomics applications 2012-03-28
Bayer–Tsinghua Univ: drug discovery, 201203– collab expansion over next 3 years 2012-03-27
Thermo Fisher–Greenough: public relations, 201203 service existent Thermo Fisher listed as client on Greenough web site 2012-03-27
Chugai–Genedata: bioinformatics, 201203– license multi-year extension for Genedata Expressionist s/w 2012-03-26
ImaginAb–Novartis: investment, 201203 financing round Series A totalling $12.5m incl lead investor Novartis Venture Funds 2012-03-26
ImaginAb–SEVERAL: investment, 201203 financing round Series A $12.5m led by Novartis Venture Funds 2012-03-26
Cytos Biotechnology–SEVERAL: investment, 201203 financing round of up to CHF37m in equity and debt led by venBio 2012-03-21
Evonik–Leibniz-Gemeinschaft: catalysts, 201203– collab extension long-term catalysis research with Leibniz Institute for Catalysis (LIKAT) 2012-03-21
Shimadzu–Sony: MALDI targets, 201203– collab extension developm application-specific + barcoded disposable MALDI targets by Kratos + Sony DADC 2012-03-21
Boehringer–Ablynx: Nanobodies, 201203–201409 collab extenstion 2y discovery up to 10 Nanobodies excl ww rights dev + manuf + marketing 2012-03-20
High-Tech Gründerfonds–Evonik: investment, 201203 investment of €2.5m in High-Tech Gründerfonds II 2012-03-20
CCS Cell Culture Service–ChromoTek: Chromobody cell lines, 201203– collab service + distribution + co-marketing by CCS 2012-03-15
CEVA–Minapharm: cell line, 201203– license €na multi-product to ProBioGen’s AGE1.CR avian cell line for production of viral animal vaccines 2012-03-15
EuroEPINOMICS project–Cartagenia: functional genomics, 201203– collab partner in RES project providing Cartagenia BENCH platform 2012-03-14
Baliopharm–Germany (govt): grant, 201203– BMBF grant €1.3m for pre-clincial + clinical development of Atrosab 2012-03-13
Univ Münster–Thermo Fisher: mass spectrometer, 201203 supply existent iCAP Q ICP-MS systems Karst group is early customer 2012-03-12
Bayer–Thompson Agronomics: soybeans, 201203 acquisition €na germplams assets of soybean breeding division ProSoy Genetics by Bayer CropScience 2012-03-09
Instituto Politécnico Nacional–Bruker Corp: mass spectrometer, 201203 supply purchase Autoflex Speed MALDI TOF/TOF mass spectrometer by CNMN 2012-03-06
Instituto Politécnico Nacional–Bruker Corp: mass spectrometer, 201203 supply purchase MicrOTOF-Q II ESI-Qq-TOF mass spectrometer by CNMN 2012-03-06
Maine Manufacturing–General Electric: protein microarray technology, 201203– acquisition excl right to commercialise FAST Protein Array product line 2012-03-06
Affimed–SAW Instruments: sam Biosensor, 201203 supply existent Affimed is sam biosensor customer of SAW 2012-03-05
Biofrontera–Maschmeyer Group: investment, 201203 as part of €11.5m capital increase Alstin acquires resulting share of 12.5% 2012-03-02
Biofrontera–SEVERAL: investment, 201203 private placement capital increase €11.5m 4.4m new shares 2012-03-02
Innovative Medicines Initiative–EU (govt): grant, 201203– funding €18.2m for ABIRISK project by IMI of €34.9m total cost 2012-03-01
Boehringer–Biocrea: PDE-2 inhibitors, 201202– acquisition €na asset purchase of Biocrea’s PDE2 inhibitors incl lead compound BCA909 2012-02-29
Danaher–Epitomics: RabMab technology, 201202– collab supply long-term rabbit MAbs for automated ICH staining systems of Leica Biosystems 2012-02-29
Lundbeck–Paion: desmoteplase, 201202 acquisition all remaining desmoteplase rights for €20.1m in cash from Paion 2012-02-28
Origenis–Germany (govt): grant, 201202– 2-year grant within m4 Cluster program to develop biomarkers for developm of LRRK2 inhibitors 2012-02-28
Axolabs–Solvay: oligonucleotide drugs, 201202– collab strategic alliance combined services lead optimisation + manuf + analytical expertise Girindus 2012-02-27
OTHER–MorphoSys: Slonomics technology, 201202– supply 3y delivery of multiple Slonomics-based DNA libraries to large biopharma company 2012-02-27
Helmholtz–Bruker Corp: mass spectrometer, 201202 supply existent Ultraflex III MALDI-TOF-TOF at Proteomics Core Facility at Helmholtz München 2012-02-26
Helmholtz–Danaher: mass spectrometer, 201202 supply existent AB Sciex 4000 QTRAP at Proteomics Core Facility at Helmholtz-Zentrum München 2012-02-26
Helmholtz–Danaher: mass spectrometer, 201202 supply existent AB Sciex 4700 Proteomics Analyzer at Dept Protein Sciences at Helmholtz-Zentrum München 2012-02-26
Helmholtz–Thermo Fisher: mass spectrometer, 201202 supply existent LTQ Orbitrap XL at Proteomics Core Facility at Helmholtz-Zentrum München 2012-02-26
Apceth–Indivumed: biomarker, 201202– collab developm tissue-based markers for solid cancers to predict response to cell/gene therapy 2012-02-22
Kairos GmbH–Univ Bochum: CentraXX web portal platform, 201202– collab further development of platform with MPC 2012-02-22
Novartis–Enanta Pharmaceuticals: HCV drug, 201202– collab + license ww $34m upfront + $406m milestones + royalties NS5A inhibitor EDP-239 2012-02-21
Xencor–Boehringer: rec protein production, 201202– service + collab developm + manufacture + supply of mABs using Xtend technology for Xencor 2012-02-21
Bayer–Texas A&M Univ: wheat breeding, 201202– collab multi-year €na developm + commercialisation of new wheat varieties Texas AgriLife Research 2012-02-17
Seiratherm–Bavaria (govt): investment, 201202 financing round with investors HTGF + Bayern Kapital 2012-02-17
Seiratherm–High-Tech Gründerfonds: investment, 201202 financing round with investors HTGF + Bayern Kapital 2012-02-17
Seiratherm–SEVERAL: investment, 201202 financing round with HTGF + Bayern Kapital + strategic investor 2012-02-17
Evotec–IR Pharma: drug discovery services, 201202– collab excl strategic alliance €na integrated drug discovery solutions for respiratory diseases 2012-02-16
KMG Chemicals–Bayer: investment, 201202 acquisition €na animal insecticide business of KMG 2012-02-16
Univ Washington–Biognosys: iRT technology, 201202 collab product integration iRT concept implemented in Skyline s/w Vers 1.2 2012-02-16
BASF–Direvo Industrial Biotechnology: feed enzymes, 201202 acquisition of optimised mannanase enzyme by BASF Animal Nutrition business 2012-02-14
4DCellFate project–EU (govt): grant, 201202– 5y FP7 grant €12m 2012-02-13
Agilent–Eppendorf: thermal cycler, 201202– license covering gradient technology for thermal cyclers to Agilent 2012-02-13
OakLabs–High-Tech Gründerfonds: investment, 201202 seed investment from HTGF 2012-02-08
Ramcon–Anagnostics: hybcell products, 201202– collab excl distribution of hybcell tests in Scandinavia by Ramcon A/S 2012-02-08
Desitin–Biofrontera: Ameluz, 201202– excl distribution + marketing in Denmark + Sweden + Norway by Desitin 2012-02-06
Materlab–Biocrates: metabolomics, 201202– collab distribution + co-marketing rights in Spain for Materlab for all Biocrates kits 2012-02-06
Onkogen Diagnostik–Biocrates: metabolomics, 201202– collab distribution + co-marketing rights in Turkey for Onkogen for all Biocrates kits 2012-02-06
Tecan–Artel: liquid handling technology, 201202– collab developm QC Kit for Freedom EVO based on Ratiometric Photometry technology 2012-02-06
Wilex–Germany (govt): grant, 201202– BMBF funding of up to €2.6m for developm of WX-037 within m4 Cluster Initiative 2012-02-06
Biofrontera–SEVERAL: investment, 201202 private placement capital increase €1.5m 500k new shares 2012-02-03
Merck (DE)–Threshold Pharmaceuticals: TH-302, 201202– co-developm + excl ww commercialistion €19m upfront + €41.5m milestones + double-digit royalties 2012-02-03
Anergis–Akampion: public relations, 201202 supply service existent 2012-02-01
BF Holding–SEVERAL: investment, 201202 capital increase MagForce AG €4.54m via 825.4k new shares at €5.5/share 2012-02-01
CovalX–Switzerland (govt): grant, 201202– KTI grant €300k for co-developm methods analysis of protein-protein interactions w Swiss academic partner 2012-02-01
next pagenext page 1 2 3 ... 37 38 39 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top